Alexis Thompson
Pediatric Hematology-Oncology · Chicago, ILNPI 1467420737
Payments from drug & device makers
What this record shows
This record is dominated by other: $1,376,333 of the $1,599,207 with a category attached, or 86.1%. Pfizer accounts for 86.3% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2022 at $1,429,100 and has fallen 99.1% since, to $12,770 in 2025. Among pediatric hematology-oncology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 96 payments — averaging $16,658 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$1.4M
- Vertex$86K
- Global Blood Therapeutics, Inc.$77K
- Bristol Myers Squibb$30K
- F. Hoffmann-la Roche AG$6K
- E.r. Squibb & Sons, L.L.C.$6K
- plus $14K from 8 others
Across 126 payments — averaging $36,620 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$2.8M
- Vertex$1.1M
- Bristol Myers Squibb$280K
- Biomarin Pharmaceutical Inc.$162K
- Novo Nordisk AS$125K
- Shire North American Group Inc$91K
- plus $93K from 3 others
What the payments were for
- Consulting fees$204,30413%
- Speaking & faculty fees$5,5250%
- Travel & lodging$11,6721%
- Food & beverage$1,3740%
- Other$1,376,33386%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 10 | $1,380,170 |
| Vertex | 36 | $85,682 |
| Global Blood Therapeutics, Inc. | 8 | $77,061 |
| Bristol Myers Squibb | 17 | $29,513 |
| F. Hoffmann-la Roche AG | 4 | $6,266 |
| E.r. Squibb & Sons, L.L.C. | 5 | $6,090 |
| Novartis | 6 | $5,661 |
| Agios Pharmaceuticals, Inc. | 1 | $3,300 |
| Genetix Biotherapeutics Inc | 4 | $3,084 |
| Novo Nordisk Health Care AG | 1 | $2,293 |
| Boston Scientific | 1 | $27 |
| Biomarin Pharmaceutical Inc. | 1 | $24 |
| AstraZeneca | 1 | $20 |
| GSK | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,599,207 in reported general payments places this provider in the 95th percentile of 78 pediatric hematology-oncology providers in Illinois.
See all pediatric hematology-oncology providers in Illinois →
Other pediatric hematology-oncology in Chicago
- Sherif BadawyChicago$329K
- Leonard ValentinoChicago$132K
- Susan CohnChicago$127K
- James LabelleChicago$88K
- Miriam BornhorstChicago$83K
- Loretta LiChicago$75K
- Sonali ChaudhuryChicago$53K
- Stewart GoldmanChicago$51K
- David JacobsohnChicago$38K
- Angela WaandersChicago$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.